From diagnosis to therapy in lung cancer

• Verfasst von: Su, Chunxia [VerfasserIn]
• Verfasst von: Meyer, Mathias [VerfasserIn]
• Verfasst von: Pilz, Lothar R. [VerfasserIn]
• Verfasst von: Schönberg, Stefan [VerfasserIn]
• Verfasst von: Henzler, Thomas [VerfasserIn]
• Verfasst von: Manegold, Christian [VerfasserIn]
• Verfasst von: Rößner, Eric [VerfasserIn]
• Titel: From diagnosis to therapy in lung cancer
• Titelzusatz: management of CT detected pulmonary nodules, a summary of the 2015 Chinese-German Lung Cancer Expert Panel
• Verf.angabe: Chunxia Su, Mathias Meyer, Robert Pirker, Wieland Voigt, Jingyun Shi, Lothar Pilz, Rudolf M. Huber, Yilong Wu, Jinghong Wang, Yonglan He, Xuan Wang, Jian Zhang, Xiuyi Zhi, Meiqi Shi, Bo Zhu, Stefan S. Schoenberg, Thomas Henzler, Christian Manegold, Caicun Zhou, Eric Dominic Roessner
• E-Jahr: 2016
• Jahr: August 2016
• Umfang: 11 S.
• Fussnoten: Gesehen am 26.05.2020
• Titel Quelle: Enthalten in: Translational Lung Cancer Research
• Ort Quelle: [S.l.] : [s.n.], 2012
• Jahr Quelle: 2016
• Band/Heft Quelle: 5(2016), 4, Seite 377-388
• ISSN Quelle: 2226-4477
• DOI: doi:10.21037/tlcr.2016.07.09
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1698795637

Abstract

The first Chinese-German Lung Cancer Expert Panel was held in November 2015 one day after the 7th Chinese-German Lung Cancer Forum, Shanghai. The intention of the meeting was to discuss strategies for the diagnosis and treatment of lung cancer within the context of lung cancer screening. Improved risk classification criteria and novel imaging approaches for screening populations are highly required as more than half of lung cancer cases are false positive during the initial screening round if the National Lung Screening Trial (NLST) demographic criteria [≥30 pack years (PY) of cigarettes, age ≥55 years] are applied. Moreover, if the NLST criteria are applied to the Chinese population a high number of lung cancer patients are not diagnosed due to non-smoking related risk factors in China. The primary goal in the evaluation of pulmonary nodules (PN) is to determine whether they are malignant or benign. Volumetric based screening concepts such as investigated in the Dutch-Belgian randomized lung cancer screening trial (NELSON) seem to achieve higher specificity. Chest CT is the best imaging technique to identify the origin and location of the nodule since 20% of suspected PN found on chest X-ray turn out to be non-pulmonary lesions. Moreover, novel state-of-the-art CT systems can reduce the radiation dose for lung cancer screening acquisitions down to a level of 0.1 mSv with improved image quality to novel reconstruction techniques and thus reduce concerns related to chest CT as the primary screening technology. The aim of the first part of this manuscript was to summarize the current status of novel diagnostic techniques used for lung cancer screening and minimally invasive treatment techniques for progressive PNs that were discussed during the first Chinese-German Lung Cancer. This part should serve as an educational part for the readership of the techniques that were discussed during the Expert Panel. The second part summarizes the consensus recommendations that were interdisciplinary discussed by the Expert Panel.